Langerhans' cell histiocytosis: current trends and the role of the head and neck surgeon.

Steven E Davis, Dale H Rice

Journal: Ear, nose, & throat journal 2004;83(5):340, 342, 344 passim

PMID: 15195882

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Langerhans' cell histiocytosis (LCH)--once called histiocytosis X--is a complex reticuloendothelial disease that often involves the head and neck. We discuss the current nomenclature of this disease and review its pathologic and clinical characteristics, with particular emphasis on the role of the head and neck surgeon. LCH can be challenging to diagnose, and the otolaryngologist must be familiar with its varied presentations. Because LCH usually responds well to medical therapy and extensive resection can easily cause more morbidity than the disease itself, a minimalist approach to treatment usually provides the best outcome. We also discuss the case of a 9-month-old girl with LCH who presented with aggressive head and neck disease.

Address: Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, 1200 N. State St., Los Angeles, CA 90033, USA.

Link outs

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Anti-Bacterial Agents, Anti-Inflammatory Agents, Antineoplastic Agents, Phytogenic, Drug Therapy, Combination, Female, Follow-Up Studies, Histiocytosis, Langerhans-Cell, Humans, Hydrocortisone, Infant, Maxillary Sinus, Mouth Diseases, Neomycin, Otolaryngology, Palate, Hard, Polymyxin B, Prednisolone, Tomography, X-Ray Computed, Vincristine